Key result
Propofol use during electroconvulsive therapy was associated with a significantly longer course of treatment, higher seizure thresholds, and increased electrical charge compared to etomidate.
Why the study?
Does etomidate compared to propofol reduce the length of course of ECT in patients receiving electroconvulsive therapy?
Population
65 patients receiving an acute course of electroconvulsive therapy (ECT)
Comparison
Etomidate as induction agent throughout the… vs Propofol as induction agent throughout the…
Design
Cohort
Authors
Loading...
Caution against preferring propofol in ECT; leaves open whether etomidate shortens courses in randomized trials.
Observational (n=65)
No
Does etomidate compared to propofol reduce the length of course of ECT in patients receiving electroconvulsive therapy?
Etomidate may be a more efficient induction agent than propofol for ECT, as propofol is associated with longer treatment courses and higher electrical charge requirements.
Patel et al. (2006) conducted an observational in Patients requiring electroconvulsive therapy (n=65). Propofol vs. Etomidate was evaluated on Length of course of ECT, adverse effects, number of missed seizures, and stimulus dose. Propofol use during electroconvulsive therapy was associated with a significantly longer course of treatment, higher seizure thresholds, and increased electrical charge compared to etomidate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: